ABDOMINAL AORTIC ANEURYSMS Clinical Trial
Official title:
Positive Impact of Endovascular Options for Treating Aneurysms Early (PIVOTAL)
NCT number | NCT00444821 |
Other study ID # | VS-2005-01 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2005 |
Est. completion date | January 2010 |
Verified date | October 2021 |
Source | Medtronic Cardiovascular |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.
Status | Terminated |
Enrollment | 728 |
Est. completion date | January 2010 |
Est. primary completion date | January 2010 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 90 Years |
Eligibility | Inclusion Criteria: - 40 to 90 years of age - Meet all indications for use as stated in the Medtronic Vascular AAA Endograft Instructions for Use - Maximum aneurysm diameter of 4-5cm - If female patient with child bearing potential, must have a documented negative pregnancy test within seven(7)days prior to inclusion - Patient is willing and able to comply with the specified follow-up evaluation - Life expectancy at least 3 years Exclusion Criteria: - Meet any of the Contraindications stated in the Medtronic Vascular AAA Endograft instructions for Use - Known co-existing condition with a life expectancy of less than 3 years - Major surgical or interventional procedure (vascular and/or non-vascular)within 30 days prior to study enrollment - Subjects enrolled in another clinical trial or anticipated to be included into a trial, which may interfere with this study, or subjects already enrolled in this trial before. - Planned conduit procedure for introduction of endograft |
Country | Name | City | State |
---|---|---|---|
United States | Albany Medical Center | Albany | New York |
United States | Lehigh Valley Hospital | Allentown | Pennsylvania |
United States | University of Michigan | Ann Arbor | Michigan |
United States | Mission / St. Joseph Hospital | Asheville | North Carolina |
United States | Tri-State Vascular Group | Ashland | Kentucky |
United States | St. Joseph's Research Institute | Atlanta | Georgia |
United States | Vascular Surgery Associates | Baton Rouge | Louisiana |
United States | Vascular Surgery Associates | Bel Air | Maryland |
United States | University of Alabama | Birmingham | Alabama |
United States | Brigham and Women's Hospital | Boston | Massachusetts |
United States | Massachusetts General Hospital | Boston | Massachusetts |
United States | University of North Carolina | Chapel Hill | North Carolina |
United States | Presbyterian Hospital | Charlotte | North Carolina |
United States | University of Virginia | Charlottesville | Virginia |
United States | University Surgical Associates | Chattanooga | Tennessee |
United States | University of Chicago | Chicago | Illinois |
United States | The Lindner Clinical Trials Center | Cincinnati | Ohio |
United States | Cleveland Clinic Foundation | Cleveland | Ohio |
United States | Ohio State University | Columbus | Ohio |
United States | Methodist Dallas Medical Center | Dallas | Texas |
United States | UT Southwestern Medical Center | Dallas | Texas |
United States | The Dayton Heart Center | Dayton | Ohio |
United States | Decatur Memorial Hospital | Decatur | Illinois |
United States | Iowa Heart Center | Des Moines | Iowa |
United States | Palomar Hospital | Escondido | California |
United States | Michigan Vascular Center | Flint | Michigan |
United States | University of Florida | Gainesville | Florida |
United States | East Carolina University | Greenville | North Carolina |
United States | Westchester Medical Center | Hawthorne | New York |
United States | Adventist Midwest Health | Hinsdale | Illinois |
United States | Baylor College of Medicine | Houston | Texas |
United States | Mayo Clinic | Jacksonville | Florida |
United States | St. John's Regional Medical Center | Joplin | Missouri |
United States | Wilford Hall Medical Center | Lackland Air Force Base | Texas |
United States | South Central Regional Medical Center | Laurel | Mississippi |
United States | Leesburg Regional Medical Center | Leesburg | Florida |
United States | VA Hospital | Little Rock | Arkansas |
United States | Long Beach VA Healthcare System | Long Beach | California |
United States | UCLA Medical Center | Los Angeles | California |
United States | University of Southern California | Los Angeles | California |
United States | Wisconsin Heart / Meriter Hospital | Madison | Wisconsin |
United States | Wellstar Clinical Trials | Marietta | Georgia |
United States | Oregon | Medford | Oregon |
United States | Baptist Memorial Hospital | Memphis | Tennessee |
United States | Cardiac Surgery Associates | Munster | Indiana |
United States | St. Thomas Hospital | Nashville | Tennessee |
United States | Vanderbilt University Medical Center | Nashville | Tennessee |
United States | Columbia University Medical Center | New York | New York |
United States | Sentara Heart Hospital | Norfolk | Virginia |
United States | Stanford University VA | Palo Alto | California |
United States | UPMC Vascular Surgery | Pittsburgh | Pennsylvania |
United States | Mayo Clinic | Rochester | Minnesota |
United States | William Beaumont Hospital | Royal Oak | Michigan |
United States | UC Davis Medical Center | Sacramento | California |
United States | North Central Heart Institute | Sioux Falls | South Dakota |
United States | Sacred Heart Medical Center | Spokane | Washington |
United States | Southern Illinois University | Springfield | Illinois |
United States | Stanford University Medical Center | Stanford | California |
United States | Staten Island University Hospital | Staten Island | New York |
United States | University of South Florida | Tampa | Florida |
United States | Texas | Temple | Texas |
United States | Jobst Vascular Center | Toledo | Ohio |
United States | Tucson Vascular Surgery | Tucson | Arizona |
United States | University of Arizona - UMC | Tucson | Arizona |
United States | Wake Forest University School of Medicine | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Medtronic Cardiovascular | The Cleveland Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Subjects That Experienced Rupture or Aneurysm Related Death | 3 years | ||
Secondary | Aneurysm Growth >0.5 cm | After repair, AAA enlargement by >0.5cm | 1 year | |
Secondary | Secondary Endovascular Procedures Between the 30-day Post Treatment and 3-year Follow-up | secondary interventions in those that had successful delivery and deployment by treatment group randomized to. | study termination |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02888613 -
Mini-laparotomy Versus Mini Lumbotomy
|
N/A | |
Recruiting |
NCT00662480 -
Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark
|
Phase 4 | |
Terminated |
NCT00372138 -
Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms
|
N/A | |
Completed |
NCT00989729 -
Preoperative Methylprednisolone in Endovascular Aortic Repair
|
N/A | |
Active, not recruiting |
NCT02345005 -
Iliac Branch Excluder ReGistry (IceBERG)
|
||
Completed |
NCT01390740 -
Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey
|
||
Completed |
NCT00833924 -
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
|
N/A | |
Terminated |
NCT00610090 -
Safety Study for the Treatment of Abdominal Aortic Aneurysms
|
Phase 2 | |
Completed |
NCT02477111 -
European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms
|
||
Recruiting |
NCT01538056 -
Physician Modified Endovascular Grafts
|
N/A | |
Completed |
NCT01106391 -
A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)
|
N/A | |
Completed |
NCT01599533 -
Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm
|
N/A | |
Completed |
NCT01328197 -
Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
|
Phase 1 | |
Completed |
NCT00705718 -
Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System
|
N/A | |
Completed |
NCT02125890 -
Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms
|
Phase 3 | |
Completed |
NCT00875563 -
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
|
N/A | |
Completed |
NCT02048514 -
The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms
|
N/A | |
Terminated |
NCT00546013 -
Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome
|
N/A | |
Recruiting |
NCT05004051 -
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
|
||
Withdrawn |
NCT03965364 -
China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)
|